Skip to main content
OVID $2.83 +1.07%
OVID logo

OVID · Ovid Therapeutics Inc.

Track OVID — free
$2.83 +0.03 (+1.07%) At close · Aug 14
Market Cap
$552.69M
Shares
195.30M
All earnings calls

Earnings call · FY2022 Q4

Ovid Therapeutics Inc. Q4 FY2022 Earnings Call

Ovid Therapeutics Inc. Q4 FY2022 Earnings Call

Concluded Mar 15, 2023
Mar 15, 2023 0 turns
Period
FY2022 Q4
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue · derived Q4 $46,280
Net income · derived Q4 -$11.50M

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document